| Item 1. |
Security and Issuer |
The Statement on Schedule 13D filed on August 24, 2018 (the “Statement”) by FCMI Parent Co. (“FCMI Parent”), FCMI Financial
Corporation (“FCMI”), Pan Atlantic Bank and Trust Limited, Friedberg Global-Macro Hedge Fund Ltd. (“G-M Fund”), Friedberg Mercantile Group, Ltd. (“FMG”) and
Albert D. Friedberg (collectively, the “Filing Persons” and each, individually, a “Filing Person”), relating to the common stock, par value $0.0001 per share (the “Common Stock”) of Vaccinex, Inc.,
a Delaware corporation (the “Issuer”), as amended by Amendment No. 1 to the Statement filed July 31, 2019, Amendment No. 2 to the Statement filed January 27, 2020, Amendment No. 3 to the Statement filed
July 16, 2020, Amendment No. 4 to the Statement filed February 14, 2022, Amendment No. 5 to the Statement filed November 29, 2022, Amendment No. 6 to the Statement filed April 5, 2023, Amendment No. 7 filed
May 25, 2023, Amendment No. 8 filed October 18, 2023, Amendment No. 9 filed February 13, 2024 and Amendment No. 10 filed August 1, 2024, is hereby further amended with respect to the matters set forth below in this
Amendment. Capitalized terms not otherwise defined herein have the meanings set forth in the Statement.
| Item 3. |
Source and Amount of Funds or Other Consideration |
Item 3 of the Statement is hereby amended by the addition of the following information:
On August 5, 2024, FCMI Parent and Mr. Friedberg acquired beneficial ownership of 3,653 shares of Common Stock through the following open-market
purchases made by FCMI Parent:
|
|
|
|
|
|
|
|
|
| Number of shares purchased |
|
Price per share ($) |
|
|
Amount paid ($) |
|
| 3,653 |
|
|
4.60 |
|
|
|
16,803.80 |
|
On August 6, 2024, FCMI Parent and Mr. Friedberg acquired beneficial ownership of 2,753 shares of Common Stock through the
following open-market purchases made by FCMI Parent:
|
|
|
|
|
|
|
|
|
| Number of shares purchased |
|
Price per share ($) |
|
|
Amount paid ($) |
|
| 2,753 |
|
|
4.92 |
|
|
|
13,544.76 |
|
| Item 4. |
Purpose of Transaction. |
Item 4 of the Statement is hereby amended by the addition of the following information:
The aggregate total of 6,406 shares of Common Stock described in Item 3 were purchased by FCMI Parent for investment purposes. The information provided in
Item 3 with respect to the 6,406 shares of Common Stock purchased is incorporated by reference herein.
The Filing Persons do not have any present
intention or arrangements to acquire additional shares of Common Stock. The Filing Persons do not have any present intention to sell any Common Stock that will be included in such Registration Statement, and note that their ability to effect
dispositions of Common Stock, other than pursuant to the Registration Statement, or prior shelf registration statements filed by the Company, may be limited by their status as “affiliates” of the Issuer.
Subject to the foregoing, the Filing Persons reserve the right to take, in the future, such actions with respect to their investment in the Issuer as they
deem appropriate. Except as described herein, the Filing Persons do not have any plans or proposals which relate to, or could result in, any of the matters referred to in paragraphs (a) through (j), inclusive, of the instructions to Item 4 of
Schedule 13D. The Filing Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto.
| Item 5. |
Interest in Securities of the Issuer. |
The table in Item 5 of the Statement showing beneficial ownership of the Issuer’s Common Stock by each of the Filing Persons, together with the
introductory paragraph to such table and the paragraph immediately following such table, as well as the information regarding ownership of the Issuer’s Common Stock by the directors and officers of the Filing Persons, are hereby amended and
restated in their entirety as follows:
On the date of this Schedule 13D (Amendment No. 11), the Filing Persons are the beneficial owners of a total
of 799,522 shares of the Issuer’s Common Stock, representing 46.3% of the Issuer’s outstanding Common Stock. Each Filing Person’s direct ownership and beneficial ownership has been computed as a percentage of 1,727,700 shares
outstanding or deemed outstanding as of August 7, 2024 plus any shares that may be acquired pursuant to presently exercisable warrants. The following table shows the number of shares of Common Stock and the percentage of the Issuer’s
Common Stock directly owned and beneficially owned by each Filing Person:
7